Navigation Links
Treating chronic pain, migraine & muscle spasticity through inhibition of neurotransmitter glutamate
Date:6/20/2008

LA JOLLA, CA, June 20, 2008 A Webinar hosted by TorreyPines Therapeutics, Inc. (NASDAQ: TPTX) at 11 a.m. EDT on June 25 will bring together industry experts to discuss the opportunity of treating chronic pain, migraine and muscle spasticity through the inhibition of the neurotransmitter glutamate.

The company's President and Chief Executive Officer, Neil Kurtz, M.D., will moderate a discussion following brief presentations by:

  • Tony Yaksh, Ph.D., Professor and Vice Chairman for Research, Department of Anesthesiology, and Professor of Pharmacology at the University of California, San Diego

    Dr. Yaksh will present information about glutamate receptors in the central nervous system as a target for chronic pain therapy. The focus of his research is the physiology and pharmacology of pain processing. A member of numerous professional societies, Dr. Yaksh has been a consultant to the U.S. Food and Drug Administration and serves on the editorial boards of several journals. He has received many awards, including the FWL Kerr Award from the American Pain Society and the American Society of Anesthesiology Award for Excellence in Research.

  • Jerome Goldstein, M.D., Director of the San Francisco Headache Clinic and a board-certified neurologist who focuses on the diagnosis, treatment, prevention and cure of headache

    Dr. Goldstein will present information about glutamate receptors in the brain as a target for acute and prophylactic migraine therapy. He is a member of the American Headache Society, The International Headache Society and The National Headache Foundation. Dr. Goldstein is a Board Certified Neurologist, a Fellow of the American Academy of Neurology, and has special qualification for the treatment of headache from the National Headache Foundation. He has received many industry awards, published articles in industry journals and served on advisory boards related to the development of a wide range of headach
    '/>"/>


Contact: Wendy Lau
wendy.lau@russopartnersllc.com
212-845-4272
Russo Partners, LLC
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. Environmental epigenetics has potential for preventing and treating disease
2. International scientists tackle obstacles to treating brain disorders
3. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
4. Massive microRNA scan uncovers leads to treating muscle degeneration
5. Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer
6. Gamma globulin effective in treating eye infections caused by adenoviruses
7. Domestic violence associated with chronic malnutrition in women and children in India
8. Diet support helps chronic kidney patients
9. SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal-induced inflamma
10. Continuous oral contraceptives better at easing pain, bleeding
11. How does the opioid system control pain, reward and addictive behavior?

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...c-level action of a remarkable class of ring-shape... with the Lawrence Berkeley National Laboratory (B...tallography beamline at the Advanced Light Source ...gene expression and replication, and are vital to ...nfectious agents, such as the human papillomavirus...
(Date:11/24/2009)..., Md. (November 24, 2009) New research on bacteri...cosystems reveals predictable temporal patterns, s...ies as markers for monitoring climate change in th... the Proceedings of the National Academy of Scien...es in the six rivers shifted synchronously over ti...
(Date:11/23/2009)..., November 23, 2009 - The time of day matters to f...ew paper produced by a research team led by Profes...rough,s vice-principal for research and colleagues...the St. George campus. , Capitalizing on their...tree, the research team examined how poplar trees ...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Time of day matters to thirsty trees, U of T researcher discovers 2HealthPlus Named One of Americas Best Health Insurance Plans Again 61201 1HealthPlus Named One of Americas Best Health Insurance Plans Again 61201 2New nanocrystalline diamond probes overcome wear 14803 1New nanocrystalline diamond probes overcome wear 14803 2Regence Partners with HealthEquity to Offer a Full Suite of Health Care Accounts 61193 1Regence Partners with HealthEquity to Offer a Full Suite of Health Care Accounts 61193 2
...ternational Institute for Species Exploration at A...ttee of taxonomists scientists responsible for sp...ce the top 10 new species described in 2008. , On...coffee and bacteria that live in hairspray. The to...ke just a slither longer than 4 inches or 104 mill...
...ging form of the pathogenic yeast Candida is abl...even though it,s missing the genes for reproductio...ding to Duke University Medical Center researchers...pecies, evolutionary success," said Joseph Heitman...l Pathogenesis in the Duke Department of Molecular...
...ax Delbrck Center for Molecular Medicine (MDC) Ber...o how mechanosensitivity arises. By measuring elec...e neurobiologists and pain researchers Dr. Stefan ...irectly elucidate, for the first time, the emergen...re able to show that neurons develop their sensiti...
Other Biology News:Scientists announce top 10 new species; issue SOS 2Scientists announce top 10 new species; issue SOS 3Scientists announce top 10 new species; issue SOS 4Scientists announce top 10 new species; issue SOS 5Yeast missing sex genes undergo unexpected sexual reproduction 2Investigating the development of mechanosensitivity 2
(Date:11/24/2009)...LENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/--DowA...etsofHylandSeeds,adivisionofThompsonsLimitedofBlen...pandDowAgroSciences,currentseedsbusinessasthecompa...010 andDowAgroSciencesHerbicideTolerantTraitTechn...nthenearfuture. ,, "Thisacquisitionbringstogeth...
(Date:11/24/2009)...v.24/PRNewswire-Asia/--NODPharmaceuticalsInc.annou...dthepatentapplicationfor,itsnano-particleoraldeliv...fficientapproachtoincorporatepeptidesor,proteinsin...drugs,otherwiseadministeredasinjections.NODtechnol...romoleculardrugssuchasinsulin,interferon,growthho...
(Date:11/24/2009)...cacyendpointhasbeenmetforpatientswithadvanced-stag...Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc.(N...maceuticalcompanyfocusedonendocrinetherapyandoncol...tudywithitstargetedcytotoxicpeptideconjugate,AEZS-...entendometrialcancer.Inapersonalizedhealthcareappr...
(Date:11/24/2009)...,November24/PRNewswire/--HealthRoboticstodayannoun...oupofselected,investors.ThisrecentlyformedToronto-...Canada,Inc.andwillmarket,install,andsupport,Health...he,revolutionaryproductofferingsi.v.STATION(TM),i....lalsoprovideassistanceonan"asneeded,basis"toitsstr...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
... high coverage and megabase capacity for the next ...ss. and HEIDELBERG, Germany, March 16 febit tod...ce capture technology HybSelect. In several biomed...st months, HybSelect demonstrated superb enrichmen... range of human genes and genomic regions. As the ...
...9.3 Percent of Outstanding Indevus Shares Have Bee...ch 16 Endo Pharmaceuticals (Nasdaq: ENDP ) anno...ime, on March 13, 2009, approximately 71,008,964 s...of guaranteed delivery) were validly tendered and ...holly owned subsidiary, BTB Purchaser Inc., repres...
...FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NA...ring research with reovirus (REOLYSIN(R)) are avai...rch (AACR) website at www.aacr.org , and on the O...The research is scheduled to be delivered at the 1...l 18-22, 2009. , The first abstract, entitled "Reo...
Other Biology Technology:Automated Sequence Capture for Next-Generation Sequencing Paves the Way for Personalized Medicine 2Automated Sequence Capture for Next-Generation Sequencing Paves the Way for Personalized Medicine 3Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009 2Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009 3Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting 2Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting 3
...icing plays an important role in the regulation of... death. Splice variants have been reported that af... apoptotic pathways. With Apoptosis and Cell Death...ion profiling and at the same time detect the diff...
...SPE Workstation is a modular, highly scalable, aut...form. Utilizing 1ml or 3ml industry standard SPE c...mples in less than two hours unattended. Each modu...modules can be connected together and controlled t...
... evolutionarily conserved form of cell suicide, wh...entral component of this process is a cascade of p... participate in a series of reactions that are tri...sult in the cleavage of protein substrates, causin...
Psoralen from Sigma-Aldrich
Biology Products: